Acceptability of Anti‑Tuberculosis Compounded Medicines at a Hospital in Bandung

Indonesian government has provided anti-TB drugs as a fixed-dose combination to eradicate tuberculosis. For pediatric patients with swallowing problems, compounded medicine is a common solution despites its stability and quality problems. Compounded medicine prescribing is intended to improve patient acceptability of medicine. Patient acceptability, especially in pediatric, will play a significant role to increase patient’s adherence, and in a bigger picture, affect its efficacy. This study was aimed to determine the acceptability level of compounded medicines and its therapy outcomes at a hospital in Bandung. This study was conducted with a cross-sectional design using accidental sampling method. Inclusion criteria were pediatric patients aged 0–14 years who have diagnosed tuberculosis and received compounded medicines. Study was held in March until November 2015 at a hospital in Bandung. A valid and reliable questionnaire was provided as an instrument to interview respondents about practicality, taste, and a smell of medicines. Total of 50 patients’ parent had participated in this study as respondent. The results showed that compounded medicine was acceptable by pediatrics patients. Acceptability of compounded medicines was affected by age factor (r=0.338). Therapeutic success of compounded medicine was achieved by 94.6% of patients with 6–9 months duration of treatment. In conclusion, the use of compounded medicines are acceptable by patients with a satisfactory outcomes therapy